隔離されたディスタル深静脈血栓症の重症患者における抗凝固薬:遡及的なコホート研究

Shengxin Fan¹, Binyan Fu¹, Jiazhou Liu¹

¹Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.

BMC cardiovascular disorders

|September 1, 2025

まとめ

早期の血液凝固抑制療法により,重症の患者では血栓の伝播が著しく減少しました. このアプローチは出血のリスクを増加させず,重症院でのDVTの管理に潜在的な利益をもたらしました.

科学分野:

集中治療薬
血管医学
血栓形成に関する研究

背景:

重症患者の孤立した遠隔深静脈血栓症 (IDDVT) に対する抗凝固薬は議論の余地があります.
この患者集団における抗凝固薬の利点の評価は極めて重要です.

研究の目的:

IDDVTと診断された重症患者の抗凝固薬の有効性と安全性を評価する.
抗凝固薬が血栓の増殖と関連する有害事象を減少させるかどうかを判断する.

主な方法:

超音波検査で診断されたIDDVTの重症患者の遡及コホート研究.
患者は抗凝固剤と非抗凝固剤のグループに分けられました.
血栓増殖,出血,死亡率を含むアウトカムを比較するために,傾向スコアマッチング (PSM) を使用した.

主要な成果:

抗凝固薬は,抗凝固薬なしと比較して,血栓の増殖を有意に減少させた (5. 7% 対 18. 9%).
PE,PDVT,または死亡率などの二次的なアウトカムでは,グループ間の有意な差異は観察されなかった.
手術は増殖の危険因子であり,早期の抗凝固薬は保護的であり,活発な悪性腫瘍,トラウマ,および高いIMPROVEスコアは出血の危険性を高めました.

結論:

早期の低用量の抗凝固薬は,IDDVTの重症患者の血栓増殖を抑えるのに有効です.
この戦略は出血のリスクを高めるようには見えません.
活動的な悪性腫瘍,トラウマ,または高IMPROVEスコアを有する患者は,高出血リスクのために注意が必要です.

キーワード:

抗凝固剤重症患者さん集中治療室隔離されたディスタル深静脈血栓症近親深静脈血栓症肺栓塞

さらに関連する動画

06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.2K

06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.1K

関連する概念動画

01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

889

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

889

01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

1.3K

01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

関連する実験動画